Key Highlights
Medicine · Neurology
This clinical case report describes an unexpected stroke recurrence following patent foramen ovale (PFO) closure that led to the diagnosis of cerebrotendinous xanthomatosis (CTX), a rare but treatable inborn error of bile acid metabolism. The authors demonstrate that in this patient, the underlying metabolic disorder—rather than the PFO alone—was the primary driver of recurrent cerebrovascular events, challenging the standard assumption that PFO closure alone is sufficient for stroke prevention in such cases. For a neuroscientist and clinician like Damien, whose PhD work involves understanding complex mechanisms underlying pain and placebo, this case underscores the importance of considering rare metabolic etiologies in recurrent stroke, reinforcing a diagnostic approach that integrates molecular pathology with structural interventions to optimize patient outcomes.
Novelty: 88%
Rigor: 82%
Significance: 91%
Validity: 85%
Clarity: 90%
Update Your Briefing Preferences
Stay curious. Stay informed —
Science Briefing
Your briefing is personalized based on your selected fields, keywords, and research interests.
